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Although milk consumption is recommended in most dietary guide-
lines around the world, its contribution to overall diet quality remains a
matter of debate in the scientiﬁc community as well as in the public
domain. This article summarizes the discussion among experts in the
ﬁeld on the place of milk in a balanced healthy diet. The evidence to
date suggests at least a neutral effect of milk intake on health out-
comes. The possibility that milk intake is simply a marker of diets
higher in nutritional quality cannot be ruled out. This review also
identiﬁes a number of key research gaps pertaining to the impact of
milk consumption on health. These need to be addressed to better
inform future dietary guidelines.Received for publication November 27, 2015. Accepted December 23, 2015.
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Bien que dans le monde entier la plupart des lignes directrices en
matière d’alimentation recommandent la consommation de lait, sa
contribution à la qualite globale du regime alimentaire reste un sujet
de controverse dans le milieu scientiﬁque ainsi que dans la sphère
publique. Cet article resume les discussions entre les experts de ce
domaine sur la place du lait dans un regime alimentaire sain et
equilibre. Les donnees probantes disponibles à ce jour suggèrent pour
le moins que la consommation de lait a un effet neutre sur la sante.
La possibilite que la consommation de lait soit simplement un mar-
queur des regimes alimentaires de qualite nutritionnelle superieure ne
peut pas être exclue. Cette revue identiﬁe egalement plusieurs
lacunes importantes de la recherche concernant les effets de la
consommation de lait sur la sante. On doit remedier à ces lacunes
pour mieux orienter les futures lignes directrices en matière
d’alimentation.Primordial and primary prevention is essential for improving
the cardiovascular health of the population in years to come.1
Primordial prevention hinges on the American Heart Associ-
ation’s “Life’s Simple Seven,” which targets 4 health behav-
iours (diet quality, physical activity, smoking, and bodyweight) and 3 health factors (cholesterol and glucose levels and
blood pressure). Nutritional quality in this paradigm is
assessed using 5 criteria: (1) fruit and vegetable consumption,
(2) ﬁsh consumption, (3) intake of whole grain cereal prod-
ucts, (4) salt intake, and (5) consumption of sugar-sweetened
beverages (SSBs).2 Although the contribution of each of these
foods to cardiovascular health is widely accepted, the extent to
which other foods, such as milk, contribute to the overall
nutritional quality of diets remains uncertain. Indeed, despite
the fact that milk/dairy consumption is recommended in most
dietary guidelines around the world, the role and place of
these commodities in a healthy/balanced diet has given rise ton Cardiovascular Society. This is an open access article under the CC BY-NC-
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Milk and Cardiometabolic Healtha highly polarized debate within scientiﬁc, media, and public
circles. On the positive side, milk contributes a signiﬁcant
proportion of daily requirements for protein and calcium at a
population level.3 When fortiﬁed, milk also contributes to
vitamin D intake. As discussed further on, calcium, vitamin
D, and dairy proteins are key nutrients for bone health.4,5
Adequate vitamin D status has also been associated with a
lower risk of some cancers and mortality,6,7 but conclusive
evidence awaits the results from ongoing large trials of vitamin
D supplementation. Milk consumption also contributes to
dietary intake of magnesium, potassium, phosphorus, vitamin
B12, riboﬂavin, and vitamin A.
In addition to having potential biological and physiological
effects per se, what milk displaces in the diet (for example
SSBs or sugary juice) is a key consideration because it may
yield further effects on health. Finally, reduced-fat milk con-
sumption has been associated with a prudent dietary pattern
in epidemiologic studies,8 raising the possibility that milk
intake may simply be a marker of a high-quality diet, having
no favorable effect per se.
On the potentially negative side, consumption of full-fat
milk contributes to saturated fat intake.3 Allergies and other
forms of intolerance to milk protein and lactose are also seen
as barriers to milk consumption.9 Finally, milk production is
facing signiﬁcant challenges related to sustainability, not only
from an economic proﬁtability perspective but also because of
environmental and societal concerns.10
Revisiting the place and role of milk in the diet is therefore
an important and timely topic, especially considering that
milk consumption is deep rooted in many occidental cultures
and is increasing markedly in many South Asian and East
Asian countries.
The International Chair on Cardiometabolic Risk (Inter-
national Chair on Cardiometabolic Risk and Lifestyle Risk
Factors section of the Supplementary Material) convened a
group of experts to assess the evidence linking milk intake
with health. Data from epidemiologic studies and randomized
controlled trials (RCTs) were reviewed. The consistency of
associations across countries and across various health out-
comes such as coronary heart disease (CHD), stroke, and type
2 diabetes was discussed. Challenges in assessing the associa-
tion between milk intake and health were discussed, and
knowledge gaps requiring future research were identiﬁed.Milk Consumption and Health Outcomes
Cardiovascular diseases
The perspective on milk and health varied minimally
among the experts, despite differences in areas of interest,
expertise, and geographic location. There was a unanimous
sense that milk intake per se was not associated with a risk of
clinical outcomes such as total cardiovascular disease (CVD),
CHD, stroke, and type 2 diabetes. Several meta-analyses on the
topic support this conclusion. Soedamah-Muthu et al.11
examined the dose-response relationship between milk intake
and overall CVD incidence in a meta-analysis of 4 cohort
studies published before 2011 based on data from a combined
sample of 13,518 individuals. Increased consumption of milk
was associated with a slightly reduced risk of CVD (composite
relative risk [RR] per 200 mL/d, 0.94; 95% conﬁdence interval[CI], 0.89-0.99). However, this was not substantiated in a
subsequent meta-analysis by O’Sullivan et al.,12 of cohort
studies combining data from more than 330,000 individuals;
they reported no signiﬁcant association between milk intake
and CVD mortality (RR per 200 mL/d, 0.96; 95% CI, 0.81-
1.13). A number of important cohort studies have been pub-
lished subsequent to these meta-analyses. For example, data
from the Japan Collaborative Cohort comprising a total of
94,980 Japanese adults aged 40-79 years followed over a period
of 19 years showed that drinking milk 1-2 times a month vs
never drinking milk was associated with lower mortality from
CVD in men (RR, 0.89; 95% CI, 0.82-0.98) but not in
women (RR, 0.99; 95% CI, 0.89-1.08).13 Among the very few
reports of a positive association between milk intake and risk of
total CVD is a recent publication from the Swedish
Mammography Cohort and the Cohort of Swedish Men
involving slightly more than 100,000 individuals who were
followed for 11-20 years.14 The study revealed a signiﬁcant
increase in the risk of CVD mortality with milk consumption
among both women (RR per 200 g/d, 1.15; 95% CI, 1.12-
1.19) and men (RR per 200g/d, 1.05; 95% CI, 1.03-1.07).
The authors were very careful in formulating their conclusions
by emphasizing the importance of confounding issues and
reverse causation to explain the discordance between their
ﬁndings and those from other groups.14 More recently, Larsson
et al.15 in their meta-analysis of the association between milk
intake and all-cause mortality concluded that there was
no consistent association between milk consumption and
mortality, including mortality from CVD, and that additional
prospective studies were needed.
Soedamah-Muthu et al.11 further examined the dose-
response association between milk consumption and risk of
CHD speciﬁcally (data from 259,162 men and women) and
stroke (data from 375,381 men and women). Increased milk
intake showed no signiﬁcant association with the risk of CHD
(RR per 200mL/d, 1.00; 95% CI, 0.96-1.04) or stroke (RR,
RR per 200 mL/d, 0.87; 95% CI, 0.72-1.07). In a meta-
analysis of 15 prospective cohort studies (n ¼ 28,138 stroke
events among 764,635 participants), Hu et al.16 reported no
signiﬁcant linear association between milk intake and the risk
of stroke. However, a highly signiﬁcant nonlinear dose-
response relationship between milk intake and risk of stroke
was observed, with the lowest risk found in the groups
consuming 200 mL/day (RR vs nonconsumers, 0.82; 95% CI,
0.79-0.86) and 300 mL/day (RR, 0.83; 95% CI, 0.79-0.86).
Milk fat intake can be ascertained using the plasma con-
centrations of fatty acids that are found speciﬁcally in dairy
fat, primarily C15:0 and C17:0.17 This approach is based on
the premise that humans have a very low endogenous pro-
duction of these fatty acids. Levels of C17:0 in plasma were
associated with a reduced risk of CHD in a meta-analysis by
Chowdhury et al.18 Recent data from Swedish studies in men
and women are at odds with previous nested case-control data
from the same cohorts,14 according to which milk fat intake
assessed by plasma concentrations of the fatty acids C15:0 and
C17:0 was inversely correlated with risk factors for metabolic
syndrome and inversely associated with the risk of myocardial
infarction in women but not in men.19 It must be stressed
that the use of such biomarkers of dairy fat intake has been
challenged recently based on data indicating active metabolic
pathways potentially inﬂuencing C15:0 and C17:0 levels in
Table 1. Summary of the association between milk consumption and
risk of disease and clinical outcomes
Outcome Association with milk intake
Total CVD Uncertain
CHD Neutral
Stroke Neutral
Type 2 diabetes Neutral
Fractures Neutral
CHD, coronary heart disease; CVD, cardiovascular disease.
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regular fat form, milk contributes a small proportion of total
dietary fat. The extent to which variations in plasma con-
centrations of C15:0 and C17:0 reﬂect variations in milk
intake remains uncertain.
In summary, although the association between milk intake
and CVD risk and morbidity remains uncertain to a degree,
the evidence so far from existing meta-analyses and subse-
quent cohort studies points toward a neutral association be-
tween milk intake and CHD risk (Table 1). More studies are
warranted to provide a more deﬁnitive answer to this
question.
Type 2 diabetes
Four meta-analyses combining data from 4-14 studies and
167,000-459,790 individuals have been relatively consistent
in showing no signiﬁcant association between milk intake and
the risk for type 2 diabetes (RR, ranging from 0.87-0.95; 95%
CI, ranging from 0.69-1.67, depending on whether total, low-
fat, or whole-fat milk was considered).21-24 Using a mendelian
randomization approach in a cohort of 97,811 Danish in-
dividuals, Bergholdt et al.25 showed that milk intake as
assessed by genetic variations related to lactose tolerance was
also not associated with the risk of type 2 diabetes. Taken
together, current data pertaining to the risk of type 2 diabetes
suggest no association with milk intake.
Bone/muscle health
The unique sets of nutrients provided by milk are believed
to be beneﬁcial for bone and muscle strength. This is a topic
of particular signiﬁcance in aging populations because costs of
treating a patient with hip fracture are about 3 times greater
than those of caring for a person without a history of hip
fracture.26 In a meta-analysis of large cohort studies including
195,102 women and 75,149 men, milk intake was not
signiﬁcantly associated with the risk of hip fracture in women
(RR per glass of milk per day, 0.99; 95% CI, 0.96-1.02),
whereas a trend toward a beneﬁt in men was suggested (RR
per glass of milk per day, 0.91; 95% CI, 0.81-1.01).27
Notably, after excluding the inﬂuential Swedish cohort
study by Michaelsson et al.,28 there was a marginally signiﬁ-
cant 5% reduction of hip fracture risk per glass of milk intake
per day in women as well (pooled RR, 0.95; 95% CI, 0.90-
1.00; P ¼ 0.049).27 A more recent analysis of another
Swedish cohort (104,000 individuals) suggested, in fact, a
small increase in the risk of any fracture (RR, 1.02; 95% CI,
1.00-1.04) or of hip fracture (RR, 1.09; 95% CI, 1.05-1.13)
per glass of milk intake among women but no association for
the risk of all fractures (RR, 1.01; 95% CI, 0.99-1.03) or hipfractures (RR, 1.03; 95% CI, 0.99-1.07) in men.14 The
extent to which the higher rates of hip fracture in these
Swedish cohorts, compared with data from other studies,27
may have inﬂuenced results is unclear.
Calcium from foods including milk is found mainly in the
form of calcium phosphate, whereas most studies on supple-
mentation have used either calcium citrate or calcium car-
bonate. This is important because the different forms of
calcium have highly variable bioavailability and, hence,
potentially different effects on bone health.29 It has been
suggested that milk intake may plausibly reduce fracture risk
through its speciﬁc calcium content and the potential syner-
gistic effect of vitamin D in promoting calcium and phosphate
absorption. In the most recent meta-analysis, calcium sup-
plementation was shown to reduce the risk of total fracture
(RR, 0.89; 95% CI, 0.81-0.96) and vertebral fracture (RR,
0.86; 95% CI, 0.74-1.00) but not hip (RR, 0.95; 95% CI,
0.76-1.18) or forearm fracture (RR, 0.96; 95% CI, 0.85-
1.09). However, in the RCTs at lowest risk of bias (4 studies;
N ¼ 44 505), there was no effect of calcium supplementation
on risk of fracture at any site. In another meta-analysis based
on 4 double-blind RCTs,30 no signiﬁcant overall beneﬁt of
calcium supplementation on risk of nonvertebral fractures was
observed. In fact, a possible adverse effect of calcium sup-
plementation on hip fracture risk was found (among 6504
individuals and 139 hip fractures: pooled RR, 1.64; 95% CI,
1.02-2.64).30
Milk may reduce fracture risk through vitamin D fortiﬁ-
cation. Much of Europe, however, does not add vitamin D to
milk. This is of particular concern in Northern European
countries (including Sweden), where endogenous production
of vitamin D by the skin is limited because of reduced
exposure to sunshine. A recent individual participant data
pooled analysis of 11 double-blind RCTs with 30,000 seniors
showed that high doses of supplemented vitamin D (median,
800 IU/20 mg daily) reduces risk of hip fracture by 30%
(hazard ratio [HR], 0.70; 95% CI, 0.58-0.86) and of any
nonvertebral fracture by 14% (HR, 0.86; 95% CI, 0.76-
0.96).31 Beneﬁts at the highest level of vitamin D intake were
fairly consistent across subgroups deﬁned by age group, type
of dwelling, baseline 25-hydroxyvitamin D level, and calcium
intake.31
To summarize, the association between milk intake and
bone strength and fractures appears to be neutral, but this
needs to be substantiated further through cohort studies and
RCTs (Table 1). Additional mechanistic studies are also
needed to better understand how milk affects bone strength
and if, and to what extent, vitamin D fortiﬁcation is critical to
support milk’s beneﬁts for bone.
Cardiometabolic risk factors
Data from observational cohort studies are fairly consistent
with data from RCTs, which in general suggest a neutral effect
of milk consumption on cardiometabolic risk factors.
Lowering plasma low-density lipoprotein cholesterol (LDL-C)
concentrations and blood pressure is considered to be the
primary clinical intervention for reducing CVD risk. However,
LDLs are heterogeneous in size and density, and smaller LDL
particles have been reported to be associated with an overall
atherogenic dyslipidemic phenotype generally associated with
Table 2. Key knowledge gaps related to milk and health and research
opportunities
 Do regular/full fat and reduced/nonfat milk products have similar or
different effects on health outcomes?
 To what extent are potential health effects of milk consumption modulated
by the foods it is replacing in the diet?
 What is the impact of milk consumption on other vascular-related disease
outcomes such as peripheral arterial disease, chronic kidney disease and
cognitive decline?
 Does milk powder have similar health properties as liquid milk?
 How do different cattle feeding practices, which modify the fatty acid
proﬁles of dairy fat, inﬂuence the effect of milk on health?
 Do age, weight status, sex, and ethnicity inﬂuence the impact of milk
consumption on health?
 Is the effect of milk consumption on health outcomes similar among
populations with traditionally low vs high intakes?
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particle number may be more important than LDL-C
concentration in determining the risk of CHD.33 Meta-
analyses of RCTs have shown that dietary saturated fatty
acids (SFAs) increase plasma LDL-C compared with carbo-
hydrates, monounsaturated fatty acids, and polyunsaturated
fatty acids.34 However, SFAs from dairy may have no effect on
LDL particle number and cholesterol levels.35,36 In fact,
studies have shown that SFAs from dairy tend to increase levels
of larger, but not smaller, LDL particles, in contrast to
carbohydrates, which increase smaller LDLs.37 The clinical
signiﬁcance of this increase in large LDLs with consumption of
SFAs from dairy remains to be determined.
In a small randomized controlled feeding trial, Drouin-
Chartier et al.38 showed that consumption of 4 cups of
partly skimmed milk (2% fat) for 6 weeks vs no milk had
virtually no impact on a wide spectrum of cardiometabolic
risk factors in postmenopausal women, including LDL-C and
other lipid risk factors, markers of vascular function, and
markers of inﬂammation. In an RCT with 158 overweight
and obese men and women, neither high protein nor SFAs
from dairy affected insulin sensitivity or plasma LDL-C, high-
density lipoprotein cholesterol, or triglyceride
concentrations.39
There has been some evidence that speciﬁc fatty acids
found in dairy fat may be associated with health beneﬁts. For
example, trans-palmitoleate (trans 16:1n-7) is a trans fatty acid
found primarily in dairy fat, and its blood phospholipid
concentrations have been associated with lower insulin resis-
tance, a more favourable lipid proﬁle, and a reduced incidence
of diabetes,40 but results have not been consistent.18 Vaccenic
acid, a trans fatty acid found in dairy fat but also in partially
hydrogenated vegetable oil, has also drawn the attention of the
research community. Several studies in animals have shown
that intake of vaccenic acid may have favourable effects on
cardiometabolic risk factors and immune function.41,42
However, these data have not yet been replicated in human
studies.43 Although of interest, studying the health impacts of
individual trans fatty acids speciﬁc to dairy fat will not fully
resolve the question of how milk as a complex food inﬂuences
health.
The association between milk intake and hypertension/
blood pressure has been quite consistent in observational
cohort studies. The meta-analysis of 7 cohort studies by
Soedamah-Muthu et al.44 assessed the dose-response associa-
tion between milk intake and the risk of hypertension. Based
on data from 47,647 individuals, each increment of 200g/d of
milk was associated with a signiﬁcant 4% reduction in the risk
of hypertension (RR, 0.96; 95% CI, 0.94-0.98). In contrast,
Benatar et al,45 in a meta-analysis of 7 RCTs published before
2013, could not conﬁrm a signiﬁcant blood pressureelow-
ering effect of total dairy intake on systolic and diastolic blood
pressure. Meta-analyses of RCTs showed inconsistent results
regarding the impact of probiotic fermented milk, with
favourable as well as neutral effects on systolic and diastolic
blood pressure.46,47 More recently, Drouin-Chartier et al.48
showed in an RCT with 76 patients with mild to moderate
hypertension that daily consumption of milk (low fat), yogurt
(low fat), and cheese (regular fat) for a total of 3 servings per
day signiﬁcantly reduced mean daytime systolic blood pressure
(e2 mm Hg; P ¼ 0.05) in men but not in women whencompared with a dairy-free control diet. Because most of the
existing RCTs have assessed the impact of total dairy rather
than milk per se on blood pressure, more studies on this topic
are clearly needed.
Both cross-sectional and longitudinal cohort studies have
shown signiﬁcant inverse relationships between dairy product
intake and measures of arterial stiffness,49,50 which has been
proposed to be a more holistic marker of vascular health and
predictor of cardiovascular events and mortality than blood
pressure per se.51 This remains controversial, however, and
more clinical studies assessing the impact of milk intake on
arterial stiffness are clearly warranted to pursue this
hypothesis.
In summary, it appears that milk consumption per se may
have relatively neutral effects on a wide spectrum of car-
diometabolic risk factors, which overall is consistent with data
from observational cohort studies. One exception pertains to a
potentially favourable effect of dairy/milk intake on blood
pressure. However, several key questions remain, as discussed
in the following section.Complexities in Assessing the Impact of Milk
on Health and Research Opportunities
Assessing the effect of milk consumption on health is
complex and requires further studies to address several
important questions relevant to clinical practice and public
health (Table 2).
Effect of replacement foods
One of the key aspects to consider when assessing the place
of milk in a healthy dietary pattern is to consider what it dis-
places in the diet. This issue requires considerable attention
because the impact of milk per se on health cannot be fully
dissociated from that of the foods it replaces. Data from a
6-month RCT indicated that isocaloric replacement of milk by
SSBs increases fat storage in the liver, muscle, and visceral fat.52
Results from observational cohort studies based on modelling
of dietary data are consistent with this in suggesting that
“substituting” SSBs for milk is associated with an increased risk
of weight gain.53 Data from 2 large US cohort studies have
shown that compared with 1 serving per day of red meat, 1
serving per day of dairy including milk was associated with an
11% (95% CI, 5%-17%) lower risk of stroke in men and
women and a 13% (95% CI, 6%-19%) lower risk of CHD in
Table 3. Key summary points
 Milk consumption is part of many cultures and is recommended in most
dietary guidelines around the world
 Evidence available to date suggests that milk has a neutral effect on most
cardiovascular outcomes, whereas milk intake may be associated with a
lower risk of hypertension
 Important research gaps need to be addressed to better understand the
impact of milk intake on health
1030 Canadian Journal of Cardiology
Volume 32 2016women.54,55 In contrast, dairy consumption in place of ﬁsh
was associated with a higher risk of CHD in women.55
However, as emphasized earlier, milk may not be comparable
to other solid sources of protein in the context of hydration and
protein functionality. This issue deserves more consideration in
future studies so that the impact of solid vs liquid foods on
health can be assessed separately, according to their speciﬁc
contribution to the overall diet.
Factors affecting nutrient composition of milk
Other aspects to consider pertain to seasonal and feeding
practiceerelated variations in milk nutrient content. For
example, indoor feeding of dairy cows increases the SFA content
of fat in milk by almost 10% compared with outdoor feeding at
high altitudes.56 Accordingly, studies in Europe and the United
States have documented seasonal changes in the fat content of
milk,57,58 with a decrease in the proportion of SFAs and an
increase trans fatty acids during the grazing season.However, the
statistically signiﬁcant differences in the fatty acid content of
milk between seasons and regions in the United States appeared
to be minor from an overall human nutrition perspective, with
SFA proﬁles that were numerically similar.58 Assessment of food
intake in observational cohort studies certainly does not capture
such variation in milk nutrient composition, whether important
or not. Hence, the extent to which accounting for such variation
in milk nutrient proﬁle will enhance our understanding of the
impact of milk consumption on health is uncertain. Whether a
reduced-SFA milk is healthier than unmodiﬁed milk is certainly
an area with great research potential.59
Whole milk (3.25% fat) in most observational cohort
studies has generally been considered a high/regular-fat
product, which may be inappropriate considering that other
full-fat dairy such as cheese contains as much as 40%-45% fat.
This is a signiﬁcant shortcoming in several of the existing
studies on milk and health. To better address this limitation,
future studies should also examine how different types of milk
based on fat content, but also perhaps on other aspects such as
fermentation and vitamin D fortiﬁcation, relate to car-
diometabolic health.
Geographic considerations
Vitamin D fortiﬁcation of milk is not systematic in Europe
but is so in the United States and Canada. The extent to
which this leads to inconsistent associations between milk
intake and health is unclear. Consumption of milk is highly
variable around the world, with trends toward reduced con-
sumption in North America and increased consumption in
Asia,60 where consumption has traditionally been very low. It
will be challenging for ongoing observational cohort studies in
these populations to account for acute upward and downward
trends in milk/dairy consumption. Asian countries are also
important consumers of milk protein powders. The impact of
this nonliquid form of milk on health is poorly characterized
compared with its liquid parent. Lactose intolerance also
needs to be factored in when assessing the impact of milk
intake on health in Asian countries.
Other disease outcomes
Further research is needed to document how milk con-
sumption inﬂuences vascular-related disease outcomes otherthan heart disease and stroke, eg, peripheral arterial disease,
chronic kidney disease, and cognitive decline.61 The extent to
which weight status, age, ethnicity, and sex modify the impact
of milk consumption on health outcomes also needs further
consideration. The expert panel did not discuss the impact of
milk intake on cancer risk. Brieﬂy, several reports and meta-
analyses of observational cohort studies have been conduct-
ed on this topic, suggesting no detrimental effect of milk
consumption on the risk of a variety of cancers,62-64 with the
exception perhaps of prostate cancer,65 although this has not
been a consistent ﬁnding.66
Conclusions
Although in principle, RCTs would be the optimal means
of assessing the impact of milk consumption per se on clinical
outcomes such as CVD, type 2 diabetes, or cancer, such
studies are for the most part not practicable, and hence it is
necessary to rely on high-quality observational cohort studies
as well as on smaller-scale clinical studies of milk effects on
surrogates of disease outcome such as cardiometabolic risk
factors. The available body of evidence is relatively consistent
in supporting a neutral effect of milk intake on multiple
health outcomes (Table 3). This raises the question about the
relevance of including milk (and dairy) as part of the guide-
lines for promoting healthy eating. However, milk con-
sumption does contribute to the intake of several important
nutrients, and this needs to be factored in when considering
the place of milk in current dietary guidelines.
This review also identiﬁes key research gaps that need to be
addressed in the future (Table 2). It will be important to
determine the intrinsic health properties of milk (eg, vitamin
D fortiﬁcation vs no fortiﬁcation) vs the effects mediated
through foods it replaces or displaces in the diet. In this re-
gard, the difference between regular-fat and reduced-fat milk
in inﬂuencing health outcomes needs to be speciﬁcally
documented. The extent to which nutrient variations in milk,
including milk SFAs, inﬂuence its association with health
outcomes also needs consideration. Potential variations by sex,
obesity status, and geographic locations regarding the impact
of milk intake on health are poorly understood. Finally, the
possibility that milk intake is simply a marker of diets with
good nutritional quality cannot be ruled out, and this concept
needs further research as well. Addressing these research gaps
will help resolve the place of milk in the healthy eating
paradigm, hence contributing to better informed evidence-
based dietary guidelines.
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